Serum apolipoprotein A-1 quantification by LC-MS with a SILAC internal standard reveals reduced levels in smokers
Qingqing Wang, Suhong Zhang, Lili Guo, Christine M Busch, Wenying Jian, Naidong Weng, Nathaniel W Snyder, Kannan Rangiah, Clementina Mesaros and Ian A Blair
Adult Aged Aged, 80 and over Amino Acid Sequence Apolipoprotein A-I - blood Case-Control Studies Chromatography, Liquid - methods Female Humans Immunoassay Isotope Labeling - methods Male Middle Aged Molecular Sequence Data Sequence Homology, Amino Acid Smoking - physiopathology Tandem Mass Spectrometry - methods
Absolute quantification of protein biomarkers such as serum apolipoprotein A1 by both immunoassays and LC-MS can provide misleading results.
Recombinant ApoA-1 internal standard was prepared using stable isotope labeling by amino acids in cell culture with [(13)C6(15)N2]-lysine and [(13)C9(15)N1]-tyrosine in human cells. A stable isotope dilution LC-MS method for serum ApoA-1 was validated and levels analyzed for 50 nonsmokers and 50 smokers.
The concentration of ApoA-1 in nonsmokers was 169.4 mg/dl with an 18.4% reduction to 138.2 mg/dl in smokers. The validated assay will have clinical utility for assessing effects of smoking cessation and therapeutic or dietary interventions in high-risk populations.